BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fang Y, Wang H. Molecular Engineering of Peptide–Drug Conjugates for Therapeutics. Pharmaceutics 2022;14:212. [DOI: 10.3390/pharmaceutics14010212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang M, Xu H. Peptide-assembled nanoparticles targeting tumor cells and tumor microenvironment for cancer therapy. Front Chem 2023;11. [DOI: 10.3389/fchem.2023.1115495] [Reference Citation Analysis]
2 Liang J, Guo R, Xuan M, Sun Q, Wu W. An Acid-Sensitive Nanofiber Conjugate Based on a Short Aromatic Peptide for Targeted Delivery of Doxorubicin in Liver Cancer. IJN 2022;Volume 17:2961-73. [DOI: 10.2147/ijn.s359642] [Reference Citation Analysis]
3 Rodríguez-mejía LC, Romero-estudillo I, Rivillas-acevedo LA, French-pacheco L, Silva-martínez GA, Alvarado-caudillo Y, Colín-castelán D, Rodríguez-ríos D, Wrobel K, Wrobel K, Lund G, Zaina S. The DNA Methyltransferase Inhibitor RG108 is Converted to Activator Following Conjugation with Short Peptides. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10390-5] [Reference Citation Analysis]
4 Wang D, Tian Y, Zhang Y, Sun X, Wu Y, Liu R, Zeng F, Du J, Hu K. An assembly-inducing PDC enabling the efficient nuclear delivery of nucleic acid for cancer stem-like cell suppression. Nanoscale 2022;14:15384-15392. [DOI: 10.1039/d2nr02118h] [Reference Citation Analysis]